TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Self-efficacy Level
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Satisfaction Surveys
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Maximum tibial acceleration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma concentration of Osteocalcin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Liver reserve capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of executive function
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Feasibility of MCED
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Safety of MCED
Endpoint domain: Adverse events/effects
Primary endpoint: 3 years Disease-Free Survival Rate
Endpoint domain: Mortality/survival
Primary endpoint: Asthma Control Test - 2
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Pain Intensity (VAS Score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mouth Opening (Active Interincisal Distance)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of Patients Who are Alive and Progression-free at One Year
Endpoint domain: Mortality/survival
Primary endpoint: Test-Retest variability of cardiac [18F]florbetaben PET uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rate of participants with vulnerable plaques in target vessels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Photopic negative response of the electroretinogram
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Diagnostic accuracy of FAPI PET-CT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of programmatic recovery
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Rate of sustained recovery
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Dose Safety for Glycerol Tributyrate
Endpoint domain: Adverse events/effects
Primary endpoint: Efficacy on oxidative phosphorylation metabolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Self-directed Learning Readiness
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Attitudes toward technology
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Sustained Response Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: average of the last seven days (VAS-7D)
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: ventilation perfusion distribution measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Radiological outcome scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical outcome score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of Postoperative Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Length of Postoperative Hospitalization
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Postoperative Laryngeal Recurrent Nerve Irritation and Injury
Endpoint domain: Adverse events/effects
Primary endpoint: Ecchymosis of the area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Pain rating scale
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Participant's future preference
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Core Muscle Thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decannulation time of the tracheostomy tube
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Sensitivity of the MID-test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of the MID-test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Beck Depression Severity
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Post-acute sequelae of COVID-19 (PASC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total expression volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Passive thoughts
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: type and frequency of pregnancy complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Daily Physical Activity
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Average number of hours/day of OFF time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection rate of upper gastrointestinal malignant lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change from Baseline in Apnea-Hypopnea Index (AHI) for GSA2 Subset
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of Participants With Solicited Administration-site Events After the First Vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Solicited Systemic Events After the First Vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Inflammatory and immune response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Moderate-to-severe acute post-surgical pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: median modified progression-free survival (mPFS)
Endpoint domain: Mortality/survival
Primary endpoint: Highest grade of thrombocytopenia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Plasma Concentration of LY3484356
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 7-day point prevalence abstinence (PPA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dried blood spot phosphatidylethanol (PEth)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Centralized pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to the first request of rescue analgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of infections requiring procedures, medication or hospitalization
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of eclamptic fits
Endpoint domain: Adverse events/effects
Primary endpoint: Nucleic acid load of pathogenic bacteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Supine-to-stand Test (SST)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: obturator functioning scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-perception of applied impression protocol
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Inflammatory biomarker levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Area under the concentration-time curve of dabigatran in plasma (AUC0-tz)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum measured concentration of dabigatran in plasma (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cytokine source identification
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Awareness of Environmental Marker
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Prevalence of RYR1-related disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: F-VASI 50 response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neuromodulation effect
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfaction device
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Concordance of the two devices
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: migraine headache pain relief
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Radiofrequency ablation procedure duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline Electrocardiography After Radiofrequency Ablation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Protein marker
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in eating disorder symptoms measured with Eating disorder Examination Questionnaire (EDE-Q)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in eating disorder symptoms measured with Eating disorder symptom list (EDSL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in time spent in moderate to vigorous physical activity (MVPA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in total movement time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Chemosensory function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Real-world disease control rate (RW DCR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Static Compliance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Sputum Volume in ml
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Generalised Anxiety Disorder-7
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean change in weekly attack frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Dose-limiting toxicities (DLTs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of adverse events (AEs), adverse events of special interest (AESIs), and serious adverse events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Metabolic findings correlation with T1 and T2 mapping
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Metastasis status of upper mediastinum lymph nodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Lymphatic system outcomes
Primary endpoint: Illness Intrusiveness Rating Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in depression score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of perinatal individuals with evidence of initiation of treatment/support
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Level of desaturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Level of lowering blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Crestal Bone Thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peri-implant Mucosal Level Changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Side effects management
Endpoint domain: Adverse events/effects
Primary endpoint: Maintenance of Gut Microbiome Balance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Extent of tongue base obstruction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IL6 level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Visual Acuity Change from Baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Post-Randomization Treatments for Proliferative Diabetic Retinopathy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Kansas City Cardiomyopathy Questionnaire (KCCQ-12)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: World Health Organization Quality of life (WHOQOL-BREF_PT)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: World Health Organization Quality of life (WHOQOL-BREF_CG)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Total weight loss (TWL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Level of thyroid hormones
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Invasive Disease-Free Survival rate
Endpoint domain: Mortality/survival
Primary endpoint: Glycemic Control (Time-in-Range)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Effectiveness of education
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Strength and muscle mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: High-grade anal lesion at 3 years
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Pain status at Follow-up (FU)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain status at FU compared to before surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Painkiller Use
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Dentine Hypersensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic accuracy of the Breakthrough Pain Assessment Questionnaire (BTPAQ)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Test-retest reliability of the Breakthrough Pain Assessment Questionnaire (BTPAQ)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Echo intensity of the vastus lateralis and rectus femoris muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Successful hCG normalization rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Three-dimensional hard and soft tissue change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Primary occlusal caries
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Vancomycin Tissue Concentration - Start of Case
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vancomycin Tissue Concentration - End of Case
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Capsule or Synovium Sample Vancomycin Tissue Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Distal Tibia Sample Vancomycin Tissue Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Talar Bone Sample Vancomycin Tissue Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Monocular, photopic best-corrected distance visual acuity (BCDVA) at 4 meters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cough Stress Test Assessment Change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Chronic Liver Failure Consortium (CLIF-C) ACLF score at Day 7
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Major congenital malformation
Endpoint domain: Mortality/survival
Primary endpoint: Percent change of penile curvature in degrees
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of peritoneal metastasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Progression-Free Survival (PFS) at 1 year
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Melatonin and Cortisol Rhythm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Stability of mitochondrial respiratory flux (O2 flux)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stability of O2 concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants retained in the study
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of Participants Who Were Either Very Satisfied or Somewhat Satisfied with the Intervention
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Proportion of Completed Intervention Sessions
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of participants with serious ADRs
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of stricture formation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Efficacy of RP2D
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with treatment-emergent adverse events (TEAEs) categorized by severity
Endpoint domain: Adverse events/effects
Primary endpoint: Maximum tolerated dose (MTD) or Maximum administered dose (MAD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants experiencing dose-limiting toxicity (DLTs)
Endpoint domain: Adverse events/effects
Primary endpoint: IBD medication adherence
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Correction of failure in critical patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Monocular Distance Visual Acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Sleep Latency (MSL)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Systemic plasma PK profile parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Legume intake (grams per day)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Relative Abundances of Bacterial Groups
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Proportion of patients finding the audio recording useful
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of patients able to discuss medical condition effectively
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Successful retrieval of cryobiopsy specimen
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Social Support
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Donation rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Identification of the parathyroid adenoma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in Penn Alcohol Craving Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Alcohol cue attentional bias
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of adverse events of special interest (AESIs) corresponding to myocarditis, pericarditis, or myopericarditis
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Bowel Urgency Severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Occurrence of major bleeding or clinically relevant non-major bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Clinically Significant Change From Baseline in Physical and Neurological Examination Findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: AUC0-t of SHR2554
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tmax of SHR2554
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progression Free Survival (PFS) in the Intent-to-Treat (IIT) Population
Endpoint domain: Mortality/survival
Primary endpoint: Progression Free Survival (PFS) in the Estrogen Receptor 1 (ESR1)-mutation Detected Population
Endpoint domain: Mortality/survival
Primary endpoint: DLPFC beta power as a biomarker of cognitive impairment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: STN local field potential biomarkers of cognitive impairment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change from Baseline Postpartum Depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from Baseline Postpartum Anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Website usability
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Microvascular skin blood flow analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Circulatory outcomes
Primary endpoint: Microdialysis perfusions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of pediatric patients developing critical illness
Endpoint domain: Mortality/survival
Primary endpoint: Proportion of pediatric patients experiencing endothelial-related organ dysfunction syndromes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes